Ameriprise’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
1,006,195
+107,876
+12% +$1.07M ﹤0.01% 1958
2026
Q1
$8.27M Buy
898,319
+75,506
+9% +$628K ﹤0.01% 2064
2025
Q4
$6.11M Buy
822,813
+697,866
+559% +$4.78M ﹤0.01% 2297
2025
Q3
$848K Buy
124,947
+22,014
+21% +$149K ﹤0.01% 3438
2025
Q2
$711K Sell
102,933
-4,724
-4% -$32.1K ﹤0.01% 3402
2025
Q1
$784K Buy
107,657
+65,239
+154% +$512K ﹤0.01% 3307
2024
Q4
$340K Buy
+42,418
New +$368K ﹤0.01% 3677

Other funds holding VMD

Ameriprise's VMD Position: Q2 2026 in Review

Ameriprise increased its Viemed Healthcare (VMD) stake by 12% in Q2 2026, buying an estimated $1.07M and bringing the position to 1,006,195 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

Ameriprise first reported a position in VMD in Q4 2024 and has held it in 7 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Ameriprise held 1,006,195 shares of Viemed Healthcare worth $11.5M as of Q2 2026.
  • Ameriprise bought 107,876 Viemed Healthcare shares in Q2 2026, an estimated $1.07M.
  • Viemed Healthcare made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1958 holding.
  • Ameriprise first reported a position in Viemed Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.